Latest News

KaloBios Chart via S&P Capital IQ

KaloBios (KBIO) Files For Bankruptcy After Ousting Shkreli

KaloBios Pharmaceuticals filed for Chapter 11 bankruptcy Tuesday night, as first reported by ValueWalk, within two weeks of CEO Martin Shkreli’s arrest on securities fraud. The drug maker’s latest move comes on the heels of its appeal of Nasdaq’s decision […]

Emerging Markets 2016 Outlook

Emerging Markets 2016 Outlook

In many respects, 2015 was a challenging year for investors in emerging markets. However, we consider many of the factors driving recent volatility to be temporary, and we are optimistic for the longer term due to several factors. The Strength […]